The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Politics

Former Biden doctor asks to delay testimony to House committee investigating mental fitness

by admin July 8, 2025
July 8, 2025
Former Biden doctor asks to delay testimony to House committee investigating mental fitness

Former White House physician Kevin O’Connor, who served as doctor to former President Joe Biden, requested a delay to his upcoming testimony before the House Oversight Committee this week.

O’Connor was scheduled to testify on Wednesday, but is now in a disagreement with the committee over the scope of the questions he will be expected to answer during his testimony. The committee, led by Chairman James Comer, R-Ky., is interviewing the doctor as part of its investigation into Biden’s mental fitness and his administration’s use of an autopen.

A lawyer for O’Connor requested the testimony be delayed to July 28 or August 4 in a letter to Comer.

‘Dr. O’Connor has legal and ethical obligations that he must satisfy and for which violations carry serious consequences to him professionally and personally,’ the letter says.

‘We are unaware of any prior occasion on which a Congressional Committee has subpoenaed a physician to testify about the treatment of an individual patient.  And the notion that a Congressional Committee would do so without any regard whatsoever for the confidentiality of the physician-patient relationship is alarming.’

A spokesman for the Oversight Committee replied in a statement that O’Connor and his legal team were merely trying to ‘stonewall’ the process. The committee is planning to move forward with Wednesday’s testimony, which O’Connor faces a subpoena to attend.

The committee said O’Connor is welcome to object to individual questions during his testimony. But O’Connor is not allowed, in the committee’s view, to delay or decline a congressional subpoena due to concerns over questions about potentially privileged information.

The debate over O’Connor’s testimony comes weeks after a former top aide to Biden, Neera Tanden, told the Oversight Committee that she was authorized to direct autopen signatures but was unaware of who in the president’s inner circle was giving her final clearance.

During Tanden’s interview before Congress last month, which lasted more than five hours, she told lawmakers that, in her role as staff secretary and senior advisor to the former president between 2021 and 2023, she was authorized to direct autopen signatures on behalf of Biden, an Oversight Committee official told Fox News.

‘Ms. Tanden testified that she had minimal interaction with President Biden, despite wielding tremendous authority,’ Comer said at the time. ‘She explained that to obtain approval for autopen signatures, she would send decision memos to members of the President’s inner circle and had no visibility of what occurred between sending the memo and receiving it back with approval. Her testimony raises serious questions about who was really calling the shots in the Biden White House amid the President’s obvious decline. We will continue to pursue the truth for the American people.’

Fox News’ Kelly Phares and Madeleine Rivera and the Associated Press contributed to this report.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Is a Chinese chain’s blood orange cold brew the future of coffee in America?
next post
Key advisor called Hunter Biden’s role on strategy call ‘inappropriate’ after he overruled legal guidance

Related Posts

Rashida Tlaib accuses Israel of intentionally killing 7...

April 3, 2024

US-Israeli citizen who was kidnapped on Oct. 7...

March 13, 2024

Karine Jean-Pierre peppered with questions about Hunter Biden...

December 7, 2024

Biden warns Netanyahu against Rafah invasion as Israel...

May 7, 2024

FBI issues spring break travel warning after American...

March 18, 2025

Can Harris use Biden’s campaign funds? And is...

July 23, 2024

Who is Pam Bondi, Trump’s new pick for...

November 23, 2024

GOP veteran-lawmakers drop scathing ‘stolen valor’ letter to...

August 22, 2024

Possible gunfire breaks out at Trump rally in...

July 14, 2024

Iran still wants a nuclear weapon despite ‘serious...

July 6, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Waymo offers teen accounts for driverless rides

      July 9, 2025
    • Boeing delivers most airplanes since late 2023 after ramping up 737 Max output

      July 9, 2025
    • Tariff Shock Spurs “Buy-the-Dip” Setups in Tesla and ON Semiconductor

      July 9, 2025
    • Trump administration moves decisively to block China from ‘weaponizing’ American farmland

      July 9, 2025
    • Trump dishes on Milley clash over leaving military equipment in Afghanistan: ‘I knew he was an idiot’

      July 9, 2025
    • TikToker knocks Harris’ ‘weird’ take on never released interview: ‘Not good’

      July 9, 2025

    Categories

    • Business (1,286)
    • Politics (3,939)
    • Stocks (1,500)
    • Uncategorized (45)
    • World News (1,279)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved